Russia successfully tested the vaccine - asking for HIV

The director of the Center for Virus and Biotechnology Research, Vektor (Russia), Alexander Sergeyev on February 6, said that Vektor has just completed a successful clinical trial of HIV virus vaccine.

According to Sergeyev, the vaccine has a strong antibody (antigen), and a mobile reaction.

Vektor said, before that, they have developed one of the most powerful and advanced vaccines in the world. As of November 1, 2011, Russia had 636,979 cases of HIV virus infection, a record number since the record began in 1987. This number has nearly doubled since 2006. A total of 104,257 HIV patients died.

It is known that HIV is an immunodeficiency virus in humans that infects immune system cells and destroys or weakens their function. Patients with this disease will have a weakened immune system and disrupt their body's ability to fight infections and diseases.

Russia successfully tested the HIV vaccine.

The transition from HIV to AIDS (Acquired Immunodeficiency Syndrome) is a period of progression and the second stage of HIV infection.

According to the report of the World Health Organization (WHO) in 2011, the number of people infected with HIV worldwide continues to increase, reaching about 33.3 million people in 2009, with 2.6 million people infected. new and 1.8 million people died of HIV / AIDS, recorded in the report.

HIV / AIDS remains one of the world's challenges, especially in low and middle-income countries. About 10 million people worldwide need antiviral treatment, but there is not enough money to treat this disease.